A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

NCT00170976 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
403
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis